2022 BioNTX iC3 Summit Brings Leaders and Changemakers to “Accelerate Life Sciences Across North Texas” »Dallas Innovates
[ad_1]
Home to start-ups and nationally recognized companies, the bioscience and healthcare innovation communities of North Texas are well-positioned to attract further industry growth.
BioNTX is a North Texas trading organization that is a connector hub for building the industry and its ecosystem, and a primary source of support and resources for the community.
Its flagship event, the iC3 Life Science Summit, brings together biotech leaders and changemakers. Industry experts discuss insights, ideas and strategies. The two-day forum will be held at Gaylord Texan in Grapevine on September 22nd and 23rd.
iC³ = Innovation x Capital x Collaboration x Commercialization
BioNTX CEO Kathleen Otto said the naming of the summit was intentional. The combination of innovation, capital, collaboration, and commercialization is why the Rife science industry is thriving in North Texas.
BioNTX says science is essential to the future of humanity and the economic well-being of the region. The focus of this year’s summit, North Life’s acceleration of his science in Texas, is a testament to that.
The iC3 Life Science Summit is where leaders meet, share ideas, showcase the broad spectrum of North Texas bioscience research, and see the latest innovations, products, and services.
Catch the Next Texas Tech Wave with the iC3
The signing event will host startups through large multinational corporations, healthcare companies, academic research institutes, innovators, investors, vendor partners and other leaders representing industry sectors such as biotech and pharma.
iC3 is designed to foster partnerships and collaboration. Attendees can connect with innovative leaders in their industry to exchange ideas, insights, trends and stories while making business connections.
Keynote speakers and topics announced
Keynote speakers include:
Jose Arrieta
Former Chief Information Officer and Chief Data Officer
U.S. Department of Health and Human Services
Brett Giroir, MD
Former Assistant Secretary of Health and Admiralty
U.S. Public Health Service Commission
Main topics are:
State of Texas Biotechnology
How Texas works together to draw national attention to the financial resources, infrastructure, communities and talent the state has to offer.
Strategies for your success, fundraising in today’s market
Learn from experts in the field how to develop a fundraising strategy to secure funding to move the runway forward.
Corporate licensing process and alliance management
Our panel provides tips on how to find the right individuals within a potential partner organization, the negotiation process, and how to maintain good partnerships.
FDA Hot Topics
FDA has many initiatives and priorities that impact the biotechnology industry. Learn about the latest FDA topics from regulatory and legal experts.
Impact of Innovation on Clinical Trials, Accelerating Patient Outcomes
Clinical research sponsors, research facilities, and service providers continue to face challenges such as retention of research participants, lack of diversity within participant populations, compliance with regulatory requirements, and data collection and management. And above all, maintain a relationship of trust with the patient. A panel of providers, sponsors, and CROs will ponder how innovation and technology can be deployed to address challenging trends.
Market assessment, access strategy, product launch
Provides a real-world perspective on best practices in market assessment and development. Market access strategy and launch preparation.
Commitment to Texas Talent: Keeping Biomakers Looking Elsewhere
Texas is a frequent destination for biopharmaceutical manufacturing due to its business-friendly climate, available real estate, and reputation for leading life science research. But to build a solid biopharmaceutical reputation and close more of these deals, it will take a lot of work between legislators, local economic development organizations, investors, and the state’s many life sciences-focused industry groups. will require better coordination, engagement, and discussion. This session brings together economic development stakeholders, workforce development professionals, and biopharmaceutical companies located in Texas to discuss what is working, what is not, and the key states for biopharmaceutical manufacturing. Discuss opportunities to jointly explore to enhance Texas’ reputation as a
New investments and strategies to advance health equity
DFW Airport’s Pharma Logistics Strategy and Support for the Regional Life Sciences Sector
DFW Airport discusses its pharmaceutical logistics and handling strategy and why it supports the life sciences sector in North Texas.
Introducing TechStars
The UNT Health Science Center in Fort Worth recently partnered with Techstars, a global investment business that provides early-stage entrepreneurs with access to capital, one-on-one mentorship and customized programming. Learn more about how Techstars helps entrepreneurs in North Texas!
Startup preparation for investor presentation
Hear from investors and management about the current funding situation and outlook for the rest of the year. The panel also explores the risks/rewards of various financing options and provides insights on how to explore such options.
Moved Office Showcase and Pitch Competition
North Texas innovation continues to grow. Hear North Texas academic institutions showcase the best technology available for licensing, collaboration, and/or acquisition.
You can also meet the 2022 NTX Rising Stars. These next-generation leaders demonstrate remarkable achievements.
Registration and information
For more details and the latest line-up information, please visit here.
Get your tickets here.
Dallas Innovates is media sponsor of the BioNTX iCE Life Science Summit.
Please be on the list.
Dallas continues to innovate every day.
Sign up for daily updates on what’s new in Dallas-Fort Worth plus:
[ad_2]
Source link